Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

A 4732: Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

A 4732 is a bill introduced in the New York House on February 6, 2025. According to its official title, it concerns: Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product. Primary sponsor: Phil Ramos (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HIGHER EDUCATION.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product, including biological products.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Phil RamosPrimary sponsorDemocraticHouse6

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REFERRED TO HIGHER EDUCATION
  2. REFERRED TO HIGHER EDUCATION

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source